Skip to content

Acupuncture for Postoperative Urinary Retention After Hemorrhoidectomy: a Randomized Controlled Trial

Acupuncture Versus Sham Acupuncture and Neostigmine for the Management of Postoperative Urinary Retention

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05898919
Enrollment
92
Registered
2023-06-12
Start date
2022-03-01
Completion date
2023-07-06
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Complications, Postoperative Urinary Retention

Brief summary

The goal of this study is to examine the efficacy of acupuncture in the management of acute postoperative urinary retention. Clinical question: Is acupuncture efficacious for postoperative urinary retention after hemorrhoidectomy compared with sham acupuncture and neostigmine. Study design: The participants who undergo hemorrhoidectomy and report postoperative urinary retention will receive one session of acupuncture or sham acupuncture or one injection of 1-mg neostigmine. The primary outcome was the time to first urination after surgery.

Interventions

OTHERAcupuncture

Acupuncture is a technique that inserts a needle into the acupuncture point to treat a condition. In this trial, we will use acupuncture to treat postoperative urinary retention.

OTHERSham acupuncture

Participants will receive sham acupuncture at sham points.

Neostigmine was injected once after postoperative urinary retention.

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Aged between 18 and 65 years * Meets the diagnostic criteria of postoperative urinary retention * Received milligan-morgan hemorrhoidectomy and general anesthesia

Exclusion criteria

* Received Diuretic drugs * Organic diseases that cause urinary retention * Severe infection in the urinary tract * Has a history of adverse reaction to neostigmine * Cognitive dysfunction that affects outcome assessment * Being pregnant

Design outcomes

Primary

MeasureTime frameDescription
The time to first urination after surgeryImmediately after first urinationThis outcome records the time period from the end of surgery to the immediately first urination.

Secondary

MeasureTime frameDescription
Bladder residual urine volume10 minutes before treatment, 0.5, 1, and 2 hours after treatment.This outcome measures the bladder residual urine volume using the ultrasound measurement.
Urination Score10 minutes before treatment, 0.5, 1, and 2 hours after treatment.The urination score ranges from 0 to 4 points. A higher score indicates more difficult to urinate.
The volume of first of urinationImmediately after first urinationThis outcome measures the total volume of the first urination after surgery.
Visual analogue score after surgery2 hours after treatment.The visual analogue score ranges from 0 to 10 cm. A higher score indicates more painful symptoms.
Adverse effects48 hours after treatmentThe adverse events will recorded by the patients and evaluated by the physicians. And the adverse events will be classified into mild and severe. Mild adverse events need no additional medical care.
Abdominal symptom scoreBefore treatment, 0.5, 1, and 2 hours after treatment.The abdominal symptom score ranges from 0 to 3 points. A higher score indicates worse abdominal symptoms.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026